WO2005014559A1 - アミド誘導体 - Google Patents
アミド誘導体 Download PDFInfo
- Publication number
- WO2005014559A1 WO2005014559A1 PCT/JP2004/011573 JP2004011573W WO2005014559A1 WO 2005014559 A1 WO2005014559 A1 WO 2005014559A1 JP 2004011573 W JP2004011573 W JP 2004011573W WO 2005014559 A1 WO2005014559 A1 WO 2005014559A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lower alkyl
- group
- tetrahydro
- phenyl
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Description
Claims
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK04748296.3T DK1652843T3 (da) | 2003-08-08 | 2004-08-05 | Amidderivater |
ES04748296.3T ES2462292T3 (es) | 2003-08-08 | 2004-08-05 | Derivados de amida |
US10/567,565 US7465748B2 (en) | 2003-08-08 | 2004-08-05 | Amide derivative |
KR1020067002614A KR101157074B1 (ko) | 2003-08-08 | 2004-08-05 | 아미드 유도체 |
SI200432152T SI1652843T1 (sl) | 2003-08-08 | 2004-08-05 | Amidni derivati |
PL04748296T PL1652843T3 (pl) | 2003-08-08 | 2004-08-05 | Pochodne amidu |
EP04748296.3A EP1652843B1 (en) | 2003-08-08 | 2004-08-05 | Amide derivatives |
AU2004263448A AU2004263448B2 (en) | 2003-08-08 | 2004-08-05 | Amide derivatives |
JP2005513013A JP4549974B2 (ja) | 2003-08-08 | 2004-08-05 | アミド誘導体 |
CA2535199A CA2535199C (en) | 2003-08-08 | 2004-08-05 | Amide derivative |
MXPA06001526A MXPA06001526A (es) | 2003-08-08 | 2004-08-05 | Derivados de amida. |
BRPI0413430A BRPI0413430B8 (pt) | 2003-08-08 | 2004-08-05 | derivados de amida os um sal destes, composição farmacêutica compreendendo os mesmos e uso destes para o tratamento de doenças em que está implicado o herpesvírus. |
NO20061100A NO335467B1 (no) | 2003-08-08 | 2006-03-07 | Amidderivater, og et farmasøytisk preparat derav som et medikament mot herpesvirus |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003290850 | 2003-08-08 | ||
JP2003-290850 | 2003-08-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005014559A1 true WO2005014559A1 (ja) | 2005-02-17 |
Family
ID=34114142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/011573 WO2005014559A1 (ja) | 2003-08-08 | 2004-08-05 | アミド誘導体 |
Country Status (19)
Country | Link |
---|---|
US (2) | US7465748B2 (ja) |
EP (1) | EP1652843B1 (ja) |
JP (1) | JP4549974B2 (ja) |
KR (1) | KR101157074B1 (ja) |
CN (1) | CN100445271C (ja) |
AU (1) | AU2004263448B2 (ja) |
BR (1) | BRPI0413430B8 (ja) |
CA (1) | CA2535199C (ja) |
CY (1) | CY1115461T1 (ja) |
DK (1) | DK1652843T3 (ja) |
ES (1) | ES2462292T3 (ja) |
MX (1) | MXPA06001526A (ja) |
NO (1) | NO335467B1 (ja) |
PL (1) | PL1652843T3 (ja) |
PT (1) | PT1652843E (ja) |
RU (1) | RU2336273C2 (ja) |
SI (1) | SI1652843T1 (ja) |
TW (1) | TW200505894A (ja) |
WO (1) | WO2005014559A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006082820A1 (ja) * | 2005-02-02 | 2006-08-10 | Astellas Pharma Inc. | 性器ヘルペス治療剤 |
WO2006082822A1 (ja) * | 2005-02-02 | 2006-08-10 | Astellas Pharma Inc. | アシクロビル耐性ヘルペスウイルスによる疾患の予防・治療剤 |
WO2006082821A1 (ja) * | 2005-02-02 | 2006-08-10 | Astellas Pharma Inc. | ヘルペスウイルスが関与する疾患の予防若しくは治療剤 |
WO2009123169A1 (ja) * | 2008-04-02 | 2009-10-08 | アステラス製薬株式会社 | アミド誘導体含有医薬組成物 |
WO2010047295A1 (ja) | 2008-10-20 | 2010-04-29 | アステラス製薬株式会社 | 帯状疱疹関連痛の予防又は治療薬 |
WO2020109389A1 (en) | 2018-11-28 | 2020-06-04 | Innovative Molecules Gmbh | Helicase primase inhibitors for treating cancer in a combination therapy with oncolytic viruses |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0402309A3 (en) * | 2001-12-21 | 2008-09-29 | Novo Nordisk As | Amide derivatives as glucokinase activators and pharmaceutical compositions containing them |
PL215132B1 (pl) * | 2002-06-27 | 2013-10-31 | Novo Nordisk As | Pochodna arylokarbonylowa jako srodek terapeutyczny, jej zastosowanie i kompozycja farmaceutyczna ja zawierajaca |
TW200505894A (en) * | 2003-08-08 | 2005-02-16 | Yamanouchi Pharma Co Ltd | Tetrahydro-2H-thiopyran-4-carboxamide derivative |
ES2399052T3 (es) | 2004-01-06 | 2013-03-25 | Novo Nordisk A/S | Heteroaril-ureas y su uso como activadores de glucocinasa |
JP5011739B2 (ja) * | 2005-02-03 | 2012-08-29 | アステラス製薬株式会社 | テトラヒドロ−2h−チオピラン−4−カルボキサミド誘導体を含有する医薬組成物 |
JP2009500378A (ja) * | 2005-07-08 | 2009-01-08 | ノボ・ノルデイスク・エー/エス | グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素 |
WO2007006760A1 (en) * | 2005-07-08 | 2007-01-18 | Novo Nordisk A/S | Dicycloalkyl urea glucokinase activators |
KR101446973B1 (ko) * | 2005-07-14 | 2014-10-07 | 트랜스테크 파르마 엘엘씨 | 우레아 글루코키나제 활성제 |
WO2008084043A1 (en) * | 2007-01-09 | 2008-07-17 | Novo Nordisk A/S | Urea glucokinase activators |
CA2675111C (en) | 2007-01-11 | 2016-04-05 | Novo Nordisk A\S | Urea glucokinase activators |
DE102008014523A1 (de) * | 2008-03-15 | 2009-09-17 | Robert Bosch Gmbh | Heizgerät |
SI2565191T1 (sl) * | 2008-05-14 | 2014-12-31 | Astellas Pharma Inc. | Derivati 4-(indol-7-ilkarbonilaminometil)cikloheksan karboksilne kisline kot EP4 receptorski antagonisti, uporabni za zdravljenje kronične ledvične odpovedi ali diabetične nefropatije |
CN108623577B (zh) * | 2018-05-08 | 2020-09-25 | 山东百诺医药股份有限公司 | 阿莫奈韦及其中间体的制备方法 |
EP3806852A1 (en) | 2018-06-12 | 2021-04-21 | vTv Therapeutics LLC | Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs |
WO2020038812A1 (en) * | 2018-08-20 | 2020-02-27 | Rijksuniversiteit Groningen | New process for the preparation of amenamevir |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997024343A1 (en) * | 1995-12-29 | 1997-07-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Phenyl thiazole derivatives with anti herpes virus properties |
WO2000029399A1 (en) * | 1998-11-12 | 2000-05-25 | Boehringer Ingelheim (Canada) Ltd. | Antiherpes compounds |
WO2002038554A1 (fr) * | 2000-11-10 | 2002-05-16 | Yamanouchi Pharmaceutical Co., Ltd. | Derives amides |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6288091B1 (en) * | 1995-12-29 | 2001-09-11 | Boehringer Ingelheim Ltd. | Antiherpes virus compounds and methods for their preparation and use |
AU3289299A (en) * | 1998-02-19 | 1999-09-06 | Tularik Inc. | Antiviral agents |
DE50008597D1 (de) * | 1999-03-08 | 2004-12-16 | Bayer Healthcare Ag | Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel |
AU5283900A (en) * | 1999-05-24 | 2000-12-12 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
WO2000071510A2 (en) * | 1999-05-24 | 2000-11-30 | Cor Therapeutics, Inc. | INHIBITORS OF FACTOR Xa |
DE10139060A1 (de) | 2001-08-08 | 2003-02-20 | Merck Patent Gmbh | Phenylderivate |
WO2003095435A1 (fr) | 2002-05-09 | 2003-11-20 | Yamanouchi Pharmaceutical Co., Ltd. | Derives d'amides |
TW200505894A (en) * | 2003-08-08 | 2005-02-16 | Yamanouchi Pharma Co Ltd | Tetrahydro-2H-thiopyran-4-carboxamide derivative |
-
2004
- 2004-07-06 TW TW093120267A patent/TW200505894A/zh unknown
- 2004-08-05 WO PCT/JP2004/011573 patent/WO2005014559A1/ja active Application Filing
- 2004-08-05 PL PL04748296T patent/PL1652843T3/pl unknown
- 2004-08-05 JP JP2005513013A patent/JP4549974B2/ja active Active
- 2004-08-05 CN CNB2004800222586A patent/CN100445271C/zh active Active
- 2004-08-05 KR KR1020067002614A patent/KR101157074B1/ko active IP Right Grant
- 2004-08-05 CA CA2535199A patent/CA2535199C/en active Active
- 2004-08-05 MX MXPA06001526A patent/MXPA06001526A/es active IP Right Grant
- 2004-08-05 RU RU2006106922/04A patent/RU2336273C2/ru active
- 2004-08-05 AU AU2004263448A patent/AU2004263448B2/en active Active
- 2004-08-05 ES ES04748296.3T patent/ES2462292T3/es active Active
- 2004-08-05 EP EP04748296.3A patent/EP1652843B1/en active Active
- 2004-08-05 DK DK04748296.3T patent/DK1652843T3/da active
- 2004-08-05 US US10/567,565 patent/US7465748B2/en active Active
- 2004-08-05 SI SI200432152T patent/SI1652843T1/sl unknown
- 2004-08-05 PT PT47482963T patent/PT1652843E/pt unknown
- 2004-08-05 BR BRPI0413430A patent/BRPI0413430B8/pt active IP Right Grant
- 2004-08-06 US US10/912,232 patent/US6903125B2/en active Active
-
2006
- 2006-03-07 NO NO20061100A patent/NO335467B1/no unknown
-
2014
- 2014-06-11 CY CY20141100425T patent/CY1115461T1/el unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997024343A1 (en) * | 1995-12-29 | 1997-07-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Phenyl thiazole derivatives with anti herpes virus properties |
WO2000029399A1 (en) * | 1998-11-12 | 2000-05-25 | Boehringer Ingelheim (Canada) Ltd. | Antiherpes compounds |
WO2002038554A1 (fr) * | 2000-11-10 | 2002-05-16 | Yamanouchi Pharmaceutical Co., Ltd. | Derives amides |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1844776A4 (en) * | 2005-02-02 | 2008-09-03 | Astellas Pharma Inc | AGENT FOR THE PREVENTION / TREATMENT OF A DISEASE CAUSED BY A HERPES ACYCLOVIR-RESISTANT VIRUS |
WO2006082820A1 (ja) * | 2005-02-02 | 2006-08-10 | Astellas Pharma Inc. | 性器ヘルペス治療剤 |
WO2006082821A1 (ja) * | 2005-02-02 | 2006-08-10 | Astellas Pharma Inc. | ヘルペスウイルスが関与する疾患の予防若しくは治療剤 |
EP1844776A1 (en) * | 2005-02-02 | 2007-10-17 | Astellas Pharma Inc. | Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus |
EP1844775A1 (en) * | 2005-02-02 | 2007-10-17 | Astellas Pharma Inc. | Therapeutic agent for herpes progenitalis |
EP1857108A1 (en) * | 2005-02-02 | 2007-11-21 | Astellas Pharma Inc. | Preventive or therapeutic agent for herpesvirus-related disease |
WO2006082822A1 (ja) * | 2005-02-02 | 2006-08-10 | Astellas Pharma Inc. | アシクロビル耐性ヘルペスウイルスによる疾患の予防・治療剤 |
EP1857108A4 (en) * | 2005-02-02 | 2008-09-03 | Astellas Pharma Inc | PREVENTIVE OR THERAPEUTIC AGENT FOR HERPES VIRUS DISEASE |
EP1844775A4 (en) * | 2005-02-02 | 2008-09-10 | Astellas Pharma Inc | THERAPEUTIC AGENT FOR THE TREATMENT OF GENITAL HERPES |
WO2009123169A1 (ja) * | 2008-04-02 | 2009-10-08 | アステラス製薬株式会社 | アミド誘導体含有医薬組成物 |
JP5381978B2 (ja) * | 2008-04-02 | 2014-01-08 | アステラス製薬株式会社 | アミド誘導体含有医薬組成物 |
US9050326B2 (en) | 2008-04-02 | 2015-06-09 | Astellas Pharma Inc. | Amido derivatives-contained pharmaceutical composition |
WO2010047295A1 (ja) | 2008-10-20 | 2010-04-29 | アステラス製薬株式会社 | 帯状疱疹関連痛の予防又は治療薬 |
WO2020109389A1 (en) | 2018-11-28 | 2020-06-04 | Innovative Molecules Gmbh | Helicase primase inhibitors for treating cancer in a combination therapy with oncolytic viruses |
Also Published As
Publication number | Publication date |
---|---|
DK1652843T3 (da) | 2014-05-05 |
NO335467B1 (no) | 2014-12-15 |
RU2336273C2 (ru) | 2008-10-20 |
KR20060073928A (ko) | 2006-06-29 |
EP1652843B1 (en) | 2014-04-02 |
TW200505894A (en) | 2005-02-16 |
BRPI0413430B1 (pt) | 2019-04-30 |
JP4549974B2 (ja) | 2010-09-22 |
PL1652843T3 (pl) | 2014-09-30 |
RU2006106922A (ru) | 2006-08-27 |
CN1832930A (zh) | 2006-09-13 |
CY1115461T1 (el) | 2017-01-04 |
JPWO2005014559A1 (ja) | 2006-10-05 |
CA2535199C (en) | 2010-12-14 |
US7465748B2 (en) | 2008-12-16 |
SI1652843T1 (sl) | 2014-06-30 |
BRPI0413430B8 (pt) | 2021-05-25 |
AU2004263448A1 (en) | 2005-02-17 |
EP1652843A1 (en) | 2006-05-03 |
NO20061100L (no) | 2006-03-07 |
CA2535199A1 (en) | 2005-02-17 |
US6903125B2 (en) | 2005-06-07 |
MXPA06001526A (es) | 2006-05-25 |
US20050032855A1 (en) | 2005-02-10 |
KR101157074B1 (ko) | 2012-06-22 |
AU2004263448B2 (en) | 2009-02-05 |
ES2462292T3 (es) | 2014-05-22 |
CN100445271C (zh) | 2008-12-24 |
TWI341311B (ja) | 2011-05-01 |
BRPI0413430A (pt) | 2006-10-17 |
US20060229295A1 (en) | 2006-10-12 |
EP1652843A4 (en) | 2010-07-28 |
PT1652843E (pt) | 2014-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005014559A1 (ja) | アミド誘導体 | |
RU2285002C2 (ru) | Производное пиридина и фармацевтическая композиция на его основе | |
CA2985348C (en) | Ebna1 inhibitors and methods using same | |
TWI450893B (zh) | Inhibition of prostaglandin D synthase in the piper Compounds | |
TW200940526A (en) | Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative | |
JP2019515878A (ja) | フッ素置換シクロプロピルアミン系化合物並びにその製造方法、薬物組成物及び使用 | |
JP3913172B2 (ja) | アミド誘導体 | |
WO2010090304A1 (ja) | アシルグアニジン誘導体 | |
JPWO2006082821A1 (ja) | ヘルペスウイルスが関与する疾患の予防若しくは治療剤 | |
JP5011739B2 (ja) | テトラヒドロ−2h−チオピラン−4−カルボキサミド誘導体を含有する医薬組成物 | |
JP3623228B1 (ja) | テトラヒドロ−2h−チオピラン−4−カルボキサミド誘導体 | |
JPWO2006082820A1 (ja) | 性器ヘルペス治療剤 | |
KR20220071199A (ko) | 4-퀴놀리논 항균 화합물 | |
KR20220075335A (ko) | 항균 화합물 | |
JP2005089451A (ja) | アミド誘導体又はその塩 | |
JPWO2006082822A1 (ja) | アシクロビル耐性ヘルペスウイルスによる疾患の予防・治療剤 | |
JP2005298449A (ja) | 4−アミノピリミジン誘導体 | |
JP2004026819A (ja) | 医薬組成物 | |
JP4832093B2 (ja) | テトラヒドロ−2h−チオピラン−4−カルボキサミド誘導体の製造方法 | |
JP2004026818A (ja) | アミド誘導体又はその塩 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480022258.6 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005513013 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12006500115 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004748296 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 617/DELNP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067002614 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2535199 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006229295 Country of ref document: US Ref document number: 2004263448 Country of ref document: AU Ref document number: 10567565 Country of ref document: US Ref document number: PA/a/2006/001526 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2004263448 Country of ref document: AU Date of ref document: 20040805 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004263448 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006106922 Country of ref document: RU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004748296 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10567565 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0413430 Country of ref document: BR |